References

Filters: Author is Ueda, Y  [Clear All Filters]
U
Ueda Y, Kobayashi T, Ikegami T, et al. Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience. J Gastroenterol. 2019;54(7):660-666. doi:10.1007/s00535-019-01561-1.
Top